NKTR SHORT 1-Year, Historical supports show more downside.

I joined NKTR at the ~12.67 in Jan. 2017. I did not see this historical chart prior to selling early 2018, and then upping the ante throughout 2018, learning more about options contracts as well. Now that I am at a loss of ~$8K, with a cost basis in the mid-40's, I see that even though Bristol-Myers Squibb made a huge investment, the trend should continue downward, barring any medical break-through, reaching supports around $28, $22, and $16. NOT FINANCIAL ADVICE. Let me know what you think. Leave a comment below. Thank you for the consideration.

評論:

A broader look at SPX, MSFT, and a couple other charts, may be showing this worsening across the board, as the charts show similarities to the drops in 2000-2001 e-market crash, worse than the 2008 recession. I pray that im wrong. The tech bubble may be ready to bust. To many companies, to many companies for investors and institutions, loans on investments, et cetera. (I capitulated. A bull turned into a bear. Sorry)

交易進行:

hmmm.

評論:

In all honesty, I am new at this and hoped this did not happen. Seeing it happen in real time is exhausting. Three January options left. Shares sold at Stop Loss.